Beware of catching a falling knife. Although GTHX has fallen dramatically, I wouldn't buy in yet. As a dividend income invester, I would avoid the company as it is not paying dividend. However if the stock were to fall 3 days consecutively, I may trade this counter as a day trader.
G1 Therapeutics to Discontinue Metastatic Colorectal Cancer Drug Trial
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
